(Q46379251)

21 December 2017

title

19F and 1H MRI detection of amyloid beta plaques in vivo (English)

1 reference

21 December 2017

magnetic resonance imaging

main subject

0 references

author name string

Makoto Higuchi

1

1 reference

21 December 2017

Nobuhisa Iwata

2

1 reference

21 December 2017

Yukio Matsuba

3

1 reference

21 December 2017

Kumi Sato

4

1 reference

21 December 2017

Kazumi Sasamoto

5

1 reference

21 December 2017

Takaomi C Saido

6

1 reference

21 December 2017

language of work or name

English

0 references

publication date

13 March 2005

1 reference

21 December 2017

published in

Nature Neuroscience

1 reference

21 December 2017

volume

8

1 reference

21 December 2017

issue

4

1 reference

21 December 2017

page(s)

527-533

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1038/nn1422

exact match

0 references

cites work

Alzheimer's disease: a central role for amyloid

1 reference

7 January 2021

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

7 January 2021

Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.

1 reference

7 January 2021

A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain

1 reference

7 January 2021

IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques

1 reference

7 January 2021

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

7 January 2021

Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain.

1 reference

7 January 2021

In vivo amyloid imaging in Alzheimer's disease

1 reference

7 January 2021

In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease

1 reference

7 January 2021

PET imaging of amyloid in Alzheimer's disease.

1 reference

7 January 2021

Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice

1 reference

7 January 2021

Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy.

1 reference

7 January 2021

Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy

1 reference

7 January 2021

Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging

1 reference

7 January 2021

Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging

1 reference

7 January 2021

MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease.

1 reference

7 January 2021

Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents

1 reference

7 January 2021

In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent

1 reference

7 January 2021

Fluoro-substituted and 13C-labeled styrylbenzene derivatives for detecting brain amyloid plaques

1 reference

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

7 January 2021

Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates.

1 reference

7 January 2021

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

7 January 2021

Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.

1 reference

7 January 2021

RARE imaging: A fast imaging method for clinical MR

1 reference

7 January 2021

Identifiers

DOI

10.1038/NN1422

1 reference

21 December 2017

1 reference

21 December 2017